|
CN1299358A
(zh)
|
1997-12-31 |
2001-06-13 |
新泽西州州立大学(拉特格斯) |
杂环拓扑异构酶毒性剂
|
|
IL137351A0
(en)
|
1998-02-12 |
2001-07-24 |
Univ Rutgers |
Heterocyclic topoisomerase poisons
|
|
CA2371728C
(en)
*
|
1999-06-11 |
2009-06-02 |
Neorx Corporation |
High dose radionuclide complexes for bone marrow suppression
|
|
US7094885B2
(en)
*
|
1999-07-11 |
2006-08-22 |
Neorx Corporation |
Skeletal-targeted radiation to treat bone-associated pathologies
|
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
|
WO2002062398A2
(en)
|
2001-01-08 |
2002-08-15 |
Neorx Corporation |
Radioactively labelled conjugates of phosphonates
|
|
EP1453812B1
(en)
*
|
2001-11-14 |
2008-08-20 |
Rutgers, The State University |
Cytotoxic agents
|
|
AU2002364953A1
(en)
*
|
2001-11-14 |
2003-06-17 |
Edmond J. Lavoie |
Topoisomerase poison agents
|
|
AU2002365161B2
(en)
*
|
2001-11-14 |
2008-07-03 |
Rutgers, The State University |
Solubilized topoisomerase poison agents
|
|
PT1465625E
(pt)
*
|
2001-11-14 |
2010-03-09 |
Univ Rutgers |
Venenos de topoisomerase solubilizados
|
|
WO2003051403A1
(en)
|
2001-12-13 |
2003-06-26 |
Dow Global Technologies Inc. |
Treatment of osteomyelitis with radiopharmaceuticals
|
|
US6992088B2
(en)
*
|
2002-08-09 |
2006-01-31 |
Rutgers, The State University Of New Jersey |
Nitro and amino substituted heterocycles as topoisomerase I targeting agents
|
|
AU2003265406A1
(en)
*
|
2002-08-09 |
2004-02-25 |
Edmond J. Lavoie |
Nitro and amino substituted topoisomerase agents
|
|
AU2003268075A1
(en)
*
|
2002-08-09 |
2004-02-25 |
Edmond J. Lavoie |
Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
|
|
AU2003290818A1
(en)
*
|
2002-11-12 |
2004-06-03 |
Edmond J. Lavoie |
Topoisomerase-targeting agents
|
|
GB0619325D0
(en)
|
2006-09-30 |
2006-11-08 |
Univ Strathclyde |
New compounds
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
EP2403856B1
(en)
|
2009-03-06 |
2012-12-19 |
Rutgers, The State University of New Jersey |
Methylenedioxybenzo [i]phenanthridine derivatives used to treat cancer
|
|
WO2010127363A1
(en)
|
2009-05-01 |
2010-11-04 |
Rutgers, The State University Of New Jersey |
Toposiomerase inhibitors
|
|
WO2011151621A1
(en)
*
|
2010-06-01 |
2011-12-08 |
Summit Corporation Plc |
Compounds for the treatment of clostridium difficile associated disease
|
|
US9920014B2
(en)
|
2013-09-19 |
2018-03-20 |
The Florida International University Board Of Trustees |
Selective inhibition of bacterial topoisomerase I
|
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
WO2017125944A1
(en)
*
|
2016-01-23 |
2017-07-27 |
Jawaharlal Nehru University (Jnu) |
Broad spectrum antibacterial activity of novel bisbenzimidazoles targeting topoisomerase ia and the synergistic composition of bisbenzimidazole with efflux pump inhibitors against pathogenic bacteria
|
|
JP2019515025A
(ja)
|
2016-04-04 |
2019-06-06 |
ラトガース ザ ステイト ユニバーシティー オブ ニュージャージー |
トポイソメラーゼ毒
|
|
JP7267563B2
(ja)
|
2017-06-27 |
2023-05-02 |
株式会社Kyulux |
発光材料、化合物、遅延蛍光体および発光素子
|
|
WO2019004254A1
(ja)
|
2017-06-27 |
2019-01-03 |
株式会社Ｋｙｕｌｕｘ |
発光材料、化合物、遅延蛍光体および発光素子
|